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ABSTRACT
The differences in efficacy and molecular mechan-
isms of platinum based anti-cancer drugs cisplatin
(CP) and oxaliplatin (OX) have been hypothesized
to be in part due to the differential binding affinity
of cellular and damage recognition proteins to
CP and OX adducts formed on adjacent guanines
in genomic DNA. HMGB1a in particular exhibits
higher binding affinity to CP-GG adducts, and the
extent of discrimination between CP- and OX-GG
adducts is dependent on the bases flanking the
adducts. However, the structural basis for this dif-
ferential binding is not known. Here, we show that
the conformational dynamics of CP- and OX-GG
adducts are distinct and depend on the sequence
context of the adduct. Molecular dynamics simula-
tions of the Pt-GG adducts in the TGGA sequence
context revealed that even though the major confor-
mations of CP- and OX-GG adducts were similar,
the minor conformations were distinct. Using the
pattern of hydrogen bond formation between the
Pt–ammines and the adjacent DNA bases, we iden-
tified the major and minor conformations sampled
by Pt–DNA. We found that the minor conformations
sampled exclusively by the CP-GG adduct exhibit
structural properties that favor binding by
HMGB1a, which may explain its higher binding affin-
ity to CP-GG adducts, while these conformations
are not sampled by OX-GG adducts because of the
constraints imposed by its cyclohexane ring, which
may explain the negligible binding affinity of
HMGB1a for OX-GG adducts in the TGGA sequence
context. Based on these results, we postulate that
the constraints imposed by the cyclohexane ring of
OX affect the DNA conformations explored by
OX-GG adduct compared to those of CP-GG
adduct, which may influence the binding affinities
of HMG-domain proteins for Pt-GG adducts, and
that these conformations are further influenced by
the DNA sequence context of the Pt-GG adduct.
INTRODUCTION
Cisplatin (CP) and Carboplatin are platinum (Pt) based
anticancer drugs used in the treatment of testicular, ovar-
ian, head, neck and nonsmall cell lung cancer (1).
Oxaliplatin (OX) is a third generation Pt drug that has
been approved for treatment of colorectal cancer and
cisplatin-resistant tumors (1). The main mode of action
of these drugs is through formation of Pt adducts on
genomic DNA, primarily on adjacent guanines. These
Pt–DNA adducts have been shown to stall replication
and transcription and recruit DNA damage recognition
proteins leading to apoptosis (1,2). The Pt–DNA adducts
are similar for CP and OX except for their carrier ligand,
which is diammine for CP and diaminocyclohexane for
OX (3–5).
A number of cellular proteins, especially those contain-
ing the HMG-domain have been shown to bind speciﬁ-
cally to Pt-GG intrastrand DNA adducts (6–13).
HMG-domain proteins that bind to Pt-GG adducts fall
into two classes: structure-speciﬁc, abundant, chromatin
architectural proteins like HMGB1 (9–11) and sequence-
speciﬁc, cell-type speciﬁc transcription factors like LEF-1
(12,13) and SRY (12). The binding of structure-speciﬁc
HMG-domain proteins to Pt–DNA adducts has been
shown to inhibit nucleotide excision repair, which may
increase the longevity of Pt–DNA adducts (14,15).
Pt–DNA adducts have also been postulated to sequester
some HMG-domain containing transcription factors that
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characteristic of tumor cells (16,17). Thus, the binding of
HMG-domain proteins to Pt–DNA could signiﬁcantly
sensitize cells to CP and OX.
Cells and tumors that are resistant to CP are generally
not cross resistant to OX. Since CP and OX form the same
adducts at the same sites on DNA, this lack of cross-
resistance is thought to be in part due to the eﬀects down-
stream of formation of CP- and OX-DNA adducts. The
diﬀerential binding aﬃnities of HMG-domain proteins to
CP- and OX-DNA adducts (13,16,18) have been proposed
to contribute to the distinctive downstream eﬀects of
CP- and OX-DNA adducts in the cell. Hence, understand-
ing the basis of the diﬀerential binding of HMG-domain
proteins to CP- and OX-DNA could lead to a better
understanding of the diﬀerential eﬃcacies of CP and OX.
The binding of HMGB1 to Pt–DNA adducts has been
characterized in great detail. HMGB1 contains two
HMG domains: domain A (HMGB1a) and domain B
(HMGB1b). HMGB1a binds more strongly than
HMGB1b to most Pt-GG DNA adducts (18). Full-
length HMGB1 binds with lower aﬃnity compared to
HMGB1a mainly due to its highly acidic C-terminal
tail, which when removed results in the tandem HMG
domains having same aﬃnity as HMGB1a (19). However,
HMGB1a binds to Pt-GG adducts with the same speciﬁ-
city as full length HMGB1 (19). Further, footprinting stu-
dies combined with site-directed mutagenesis have shown
that only domain A of full-length HMGB1 binds to DNA
containing the Pt-GG DNA adduct (19,20). Thus, most
of the structural and mechanistic studies have been per-
formed with HMGB1a alone.
Like most structure-speciﬁc HMG-domain proteins
HMGB1 has been shown to recognize and bind to pre-
bent/distorted DNA and bend it further (12). A crystal
structure of HMGB1a in complex with CP-GG DNA in
the TGGA sequence context has been reported (21). That
structure, coupled with site-directed mutagenesis (20),
has provided considerable insight into the mechanism
of HMGB1a binding to Pt–DNA adducts. There are a
number of hydrophobic and hydrogen bond interactions
between HMGB1a and the minor groove of DNA on the
30 side of the CP-GG adduct. Among these interactions,
the most signiﬁcant appears to be the intercalation of
Phe37 between the two Gs of the Pt-GG adduct, which
allows a p–p stacking interaction between Phe37 and the
30G. Mutation of Phe37 to Ala resulted in more than
667-fold decrease in binding aﬃnity (20). The crystal
structure of HMGB1a bound to Pt–DNA in the TGGA
sequence context also shows a hydrogen bond between
Ser41 and the N3 atom of Adenine 30 of the Pt-GG
adduct. A Ser41Ala mutation resulted only in a 3.9-fold
decrease in binding aﬃnity, a much weaker eﬀect than
the Phe37Ala mutation (20). The contributions of other
interactions between HMGB1a and the minor groove of
Pt–DNA adducts to the binding aﬃnity of the protein–
DNA complex have not been characterized, but are likely
to be less than or equal to the Ser41-30A-N3 interaction.
Given that HMG-domain proteins bind Pt–DNA
adducts along the minor groove and do not directly con-
tact the drug (which is covalently bound in the major
groove), the carrier ligand does not have a direct role to
play in the binding of HMG-domain proteins. However, if
the carrier ligand were to inﬂuence the extent of distortion
of Pt–DNA to a conformation that favors binding of
HMG-domain proteins, the binding aﬃnities of HMG-
domain proteins to CP- and OX-DNA could be inﬂuenced
in that fashion. For example, in the case of HMGB1a,
conformations that favor bending of the DNA, stacking
of Phe37 with the 30G or formation of a hydrogen bond
between Ser41 and the 30A in the TGGA sequence context
would be expected to enhance binding.
The diﬀerential binding aﬃnity of HMGB1a towards
CP- and OX-DNA is also dependent on the identity of
bases ﬂanking the central intrastrand GG (11,18). The
binding aﬃnity of HMGB1a for CP-DNA adducts has
been shown to be  53 times greater than that for
OX-DNA adducts in the TGGA sequence context (18),
while in the AGGC (18) and the CGGA (11) sequence
contexts, the binding aﬃnity for CP-DNA is only three
times greater than that of OX-DNA adducts (Supplemen-
tary Text S1). In the TGGT sequence contest, the binding
aﬃnity of HMGB1a for CP-GG and OX-GG adducts is
almost the same (11). Most of the sequence-dependent
variations in diﬀerential binding aﬃnity of HMGB1a
towards CP- and OX-DNA adducts is due to sequence
dependent eﬀects for binding to OX-DNA adducts since
the binding aﬃnity of HMGB1a for CP-GG adducts
is roughly comparable in all three sequence contexts
(11,18). This sequence dependent eﬀect has also been
shown for HMGB1b and TBP, but the trends are slightly
diﬀerent (18). Thus, the increased binding aﬃnity of
HMGB1a towards CP-GG adducts compared to
OX-GG adducts in most sequence contexts suggests that
the structures of CP- and OX-GG adducts should exhibit
signiﬁcant diﬀerences which would lead to diﬀerential
recognition. The sequence context based eﬀects would
also suggest that the preferential binding conformations
are highly dependent on the bases ﬂanking the Pt–GG
adduct.
Surprisingly, the crystal and solution structures of both
CP- and OX-GG adducts in the TGGT and the AGGC
sequence contexts do not reveal signiﬁcant structural
diﬀerences (1,22–25) that can explain the diﬀerences in
binding aﬃnities of HMG-domain proteins for CP- and
OX-DNA. Hence, we have postulated that the diﬀerences
in conformational dynamics of CP- and OX-DNA
adducts might be responsible for the diﬀerential recogni-
tion of these adducts by HMG-domain proteins. To
test this hypothesis, we performed all-atom molecular
dynamics simulations on undamaged 12-mer DNA and
CP- and OX-GG 12-mer DNA adducts both free in solu-
tion and in complex with HMGB1a. All of these simula-
tions were performed in the TGGA sequence context in
which the discrimination of HMGB1a between CP- and
OX-GG adducts is 53-fold. These simulations were com-
pared with previous simulations in the AGGC sequence
context (26) in which the discrimination between CP- and
OX-GG adducts by HMGB1a is 3-fold.
Initial studies involving all-atom, fully solvated MD
simulations of CP- and OX-DNA in the AGGC sequence
context had revealed the formation of hydrogen bonds
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bases (26). CP- and OX-GG adducts in the AGGC
sequence context diﬀered in the pattern of hydrogen
bond formation between Pt-amine hydrogens and the sur-
rounding DNA bases and these diﬀerences in hydrogen
bond patterns correlated with diﬀerences in DNA confor-
mational dynamics that might be important for binding of
HMG-domain proteins.
In the TGGA sequence context, the pattern of hydrogen
bond formation between the Pt-amine hydrogens and the
surrounding bases is diﬀerent than that seen in the AGGC
sequence context. These diﬀerent patterns of hydrogen
bond formation correlate with certain conformations
that could favor binding to HMG-domain protein that
are sampled only by CP-DNA, while the conformations
favorable for HMG-domain protein binding had been
sampled by both CP- and OX-DNA to diﬀerent extents
in the AGGC sequence context (26).
METHODS
Startingstructures
We performed simulations on a 12-mer DNA sequence
(shown in Scheme 1), which was either undamaged or
covalently bound to CP or OX at the N7 of G6 and G7.
The initial structures for the CP- and OX-TGGA simula-
tions were obtained by modifying the NMR structure of
OX-DNA in the TGGT sequence context (unpublished
results). We chose this structure because, of the NMR
solution structures of Pt–DNA adducts that we have
obtained, it was the closest in sequence to the TGGA
sequence context. Using INSIGHT II (Accelrys Inc.,
CA, USA), the T8-A17 base pair was replaced by the
A8-T17 base pair in the TGGT NMR structure to
obtain the initial structure of OX-DNA in TGGA
sequence context. Further, OX was modiﬁed to CP to
obtain CP-DNA structure in the TGGA sequence context.
INSIGHT II was used to generate canonical B-DNA
structure, which was used as the starting structure for
simulations of the undamaged DNA.
For the simulations of HMGB1a-Pt–DNA complex,
we used the crystal structure of rat HMGB1a bound to
CP-DNA in the TGGA sequence context as the starting
structure for the CP-TGGA simulations [PDB ID 1ckt
(21)]. This structure was modiﬁed appropriately using
Insight II to generate starting structures for OX-TGGA,
CP-AGGC and OX-AGGC simulations.
Molecular dynamics simulations
We performed 5 sets of 10ns simulations for each of CP-,
OX- and undamaged DNA. The ﬁve sets had the same
starting structures but the initial velocities were rando-
mized. We employed simulation protocols identical to
our published work on the AGGC sequence context
(26). We performed a single MD production run of 50ns
for the HMGB1a-Pt–DNA complex in two sequence con-
texts and with CP and OX to yield four trajectories. The
details of the force ﬁeld and simulation protocols are
described in Supplemental Material S2.
Analysis: hydrogen bonds
All the trajectories were analyzed for the presence of
hydrogen bonds between all possible donors and acceptors
based on a distance cut-oﬀ of 3.5A ˚ between the donor and
acceptor and an angular cut-oﬀ of 1358 between donor-H-
acceptor. In addition to the Watson–Crick interactions,
hydrogen bonds were formed for a signiﬁcant amount of
time between Pt-amines and the surrounding base pairs.
All the frames of the trajectory were classiﬁed based on
the type of hydrogen bonds formed between Pt-amines
and the adjacent bases.
Centroid structures
We calculated the average structures for both the complete
ensembles of CP-, OX- and undamaged DNA and also for
the ensembles forming diﬀerent hydrogen bonds. Since
average structures are not actual structures from simula-
tions and may feature some abnormal bond lengths/
angles, we assigned the structure from each ensemble
that had the lowest mass-weighted root-mean-square devi-
ation (RMSD) to the average structure as the centroid
structure of that ensemble (26).
Comparisons of centroid structures using RMSD
We compared the centroid structures of CP- and
OX-DNA adducts in TGGA and AGGC sequence con-
texts respectively. In these comparisons, we used only the
atoms from the DNA part of the molecule in calculating
the mass-weighted RMSD.
Helical parameters
Helical parameters were calculated for each snapshot of
the trajectory using the CURVES program, version 5.3
(27). The following CURVES parameters were extracted:
global inter base-pair parameters: shift, slide, rise, tilt, roll
and twist; global base–base parameters: shear, stretch,
stagger, buckle, propeller and opening. Histograms were
then constructed for each of these parameters as frequency
of occurrence versus discrete units of each DNA helical
parameter. The discrete units (bin width) were set as 0.2A ˚
for all the distance parameters and 28 for all the angular
parameters. Histograms were plotted for parameters
corresponding to the central 4bp of the DNA oligomer
(the adduct is formed on central 2bp). These distributions
were also clustered on the basis of the pattern of hydrogen
bond formation between the DNA and the drug.
                           5678 
TGGA sequence context: 5’-d(CCTCTGGACTCC)-3’ 
        3’-d(GGAGACCTGAGG)-5’ 
 
               5678 
AGGC sequence context: 5’-d(CCTCAGGCCTCC)-3’ 
   3’-d(GGAGTCCGGAGG)-5’ 
 
Scheme 1. Dodecamer sequences used in simulations.
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cal parameters corresponding to CP-, OX-DNA and
undamaged DNA and also between diﬀerent hydrogen
bonded species in CP- and OX-DNA, we used the
Kolmogorov–Smirnov (KS) test (28). The lower cut-oﬀ
threshold of signiﬁcant diﬀerences was calculated by
dividing each data set into ﬁve equal subsets and perform-
ing KS test comparing all possible combinations of the
ﬁve subsets of divided data. The highest –log(P) among
the subsets of each data set was set as the threshold for
that data set. When two data sets were compared, the
diﬀerence between them was signiﬁcant only if –log(P)
of the comparison of the data sets was higher than the
threshold. The ratio of –log(P) of the comparison of the
data sets to their thresholds was calculated and then this
ratio for all the parameters are represented as colors in a
diagram (heat map). The ratios transition from white
(lowest ratios) to blue then red (highest ratios) in the
heat map. The range of KS ratios and their corresponding
color are shown as a scale in the bottom of the heat maps.
In order to compare the helical parameters of free
Pt–DNA in solution to those of Pt–DNA bound to
HMGB1a, we calculated the helical parameters by consid-
ering only the central 12bp of the longer (16bp) DNA
present in the HMGB1a-Pt-DNA complex.
Bend angle
Overall bend angles of the snapshots from the simulations
were calculated using the program MADBEND (29).
MADBEND uses the local tilt and roll parameters from
the CURVES (version 5.3) output to calculate the overall
bend angle. The bend angle was calculated for the central
10bp of the oligomer centered at G6-G7 where the Pt
adduct is formed. The normalized histograms were plotted
for bend angle versus percent occupancy with a bin width
of 28. The bend angle values were also clustered on the
basis of the type of hydrogen bond formed.
RESULTS
We performed simulations of CP- and OX-GG adducts
both with and without bound HMGB1a to probe for con-
formational diﬀerences that would explain the increased
aﬃnity of HMGB1a for CP-GG adducts compared to
OX-GG adducts in general and the much greater aﬃnity
of HMGB1a for CP-GG adducts compared to OX-GG
adducts in the TGGA sequence context. The simulations
attained equilibrium within the ﬁrst few nanoseconds,
with the all-atom mass weighted RMSD of OX- and unda-
maged DNA remaining <3A ˚ and that of CP-DNA
remaining <4A ˚ throughout the simulation (Supplemen-
tary Figure S1). The all-atom mass weighted RMSDs
of protein and DNA in simulations of HMGB1a-Pt–
DNA equilibrated within 5ns and did not exceed 5A ˚
(S. Ramachandran, B. Temple, S. G. Chaney and N. V.
Dokholyan; manuscript in preparation).
The centroid structuresof CP- and OX-DNA donot reveal
major differences
We ﬁrst compared the centroid structures of CP- and
OX-DNA simulations in the TGGA and the AGGC
sequence contexts (Figure 1). The all-atom RMSD was
 2A ˚ when we compared either CP-TGGA with
CP-AGGC or OX-TGGA with OX-AGGC, indicating
lack of global structural diﬀerences in the major confor-
mations sampled by CP- and OX-DNA adducts in the two
sequence contexts. Even when we compared the centroid
structures of CP- and OX-DNA in the TGGA sequence
context (Figure 1C, RMSD=1.98A ˚ ), there were no large
conformational diﬀerences. The same comparisons for the
central 4bp of the centroid structures (Figure 1D–F)
yielded the same conclusion: the centroid structures did
not display any major structural diﬀerences that would
warrant high diﬀerential binding aﬃnities between
CP- and OX-DNA adducts.
The overallconformation of CP- and OX-GG adducts
aresimilar
To further characterize the conformations sampled by
CP- and OX-DNA adducts in the vicinity of platinum in
the TGGA sequence context, we calculated the helical
parameters of the central 4bp of the dodecamer
(T5G6G7A8) and the 3-bp steps between them. With six
parameters describing each base pair and six more for
each base-pair step, there were a total of 42 helical para-
meters corresponding to the central 4bp. We used the KS
ratio (as described in Methods section) as a test for signif-
icant diﬀerence in comparing any two distributions of a
particular helical parameter. To identify the parameters
that showed major diﬀerences across diﬀerent compari-
sons, we plotted the KS ratio of all the 42 parameters as
a heat map (described in Methods section) of KS ratios of
diﬀerent comparisons. From the heat map, we selected
the parameters that exhibited signiﬁcant diﬀerences.
When we compared the overall distributions of the helical
parameters for CP-, OX- and undamaged DNA in the
TGGA sequence context, both CP- and OX-DNA had
signiﬁcantly diﬀerent conformations compared to unda-
maged DNA, especially in the G6-G7 base-pair step,
G6-C19 base pair and G7-C18 base pair (Supplementary
Figure S2). When comparing CP- and OX-DNA, we
observed diﬀerences in T5-G6 slide, A8-T17 buckle,
T5-A20 opening and G6-C19 opening (Supplementary
Figure S2). However, the diﬀerences between CP- and
OX-DNA were minor, yielding KS ratios of  2. Thus,
the CP- and OX-TGGA adducts appear to sample the
same major DNA conﬁrmations when examined by this
criteria.
The patternand frequencyof hydrogen bond formation
between thedrug and DNA dependboth onthe sequence
contextand carrier ligand
An earlier study had reported the formation of hydrogen
bonds between platinum amines and adjacent bases in
the AGGC sequence context (26), which correlated with
minor conformational diﬀerences between CP- and
OX-AGGC adducts that could inﬂuence the binding of
HMGB1a to these adducts. We examined the trajectories
of CP- and OX-TGGA adducts for hydrogen bond
formation between all possible donors and acceptors
using distance and angle criteria (as described in
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gen bonds in the DNA, we also observed the formation of
hydrogen bonds between Pt-amines and adjacent base
pairs. When we compared the hydrogen bond patterns
in the two sequence contexts, we observed that the bases
involved and the frequency of formation of these hydro-
gen bonds were dictated both by the sequence context and
the carrier ligand (Table 1).
In the AGGC sequence context, although the same
hydrogen bonds were formed by both CP- and OX-Pt-
amines, the frequency of hydrogen bond formation was
diﬀerent (26). The hydrogen bond to A5-N7 was formed
more frequently for CP-DNA while the hydrogen bond to
G7-O6 was formed more frequently for OX-DNA (26). In
the TGGA sequence context, the G7-O6 hydrogen bond
was formed by both CP- and OX-DNA and like in AGGC
sequence context, the G7-O6 hydrogen bond was formed
more frequently by OX-DNA (Table 1). Other hydrogen
bonds seen in the TGGA sequence context were unique to
either CP- or OX-DNA. OX-DNA formed hydrogen
bonds on the 50 side of the adduct, to T5-O30 but only
for a small fraction of time (6%, Table 1). On the 30
side, CP formed hydrogen bond with A8-N7 with a fre-
quency of 13% while OX formed hydrogen bonds with
T17-O4 with a frequency of 15%. These hydrogen bond
patterns in the TGGA sequence context that were unique
to CP- and OX-DNA adducts (A8-N7 for CP-DNA,
T17-O4 and T5-O30 for OX) all represented relatively
minor conformations (occurring  15% of the time) of
the Pt–DNA adduct. Even though these conformations
were transient, it was thought possible that the diﬀerent
hydrogen bonded conformations could inﬂuence protein
binding.
Platinum amines inOX are more constrained
compared toCP
To determine the origin of diﬀerences between CP- and
OX-DNA in the frequency of hydrogen bond formation
with ﬂanking bases on both sides of the Pt-GG adduct and
their occupancy, we calculated the distributions of geo-
metrical parameters of Pt from the simulations. As
expected from the constraints imposed by the cyclohexane
Figure 1. Comparison of centroid structures. Structural alignment of the centroid structures using only the atoms from the DNA part of the
molecule from the simulations of CP-DNA in AGGC and TGGA sequence contexts (A), OX-DNA in AGGC and TGGA sequence context
(B) and CP- and OX-DNA in TGGA sequence context (C). The structural alignment of the central four base-pairs of the centroid structures of
CP-DNA in AGGC and TGGA sequence contexts (D), OX-DNA in AGGC and TGGA sequence context (E) and CP- and OX-DNA in TGGA
sequence context (F).
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angle had a signiﬁcantly greater range for the CP-DNA
adduct compared to the OX-DNA adduct (Figure 2B) and
the greater range for CP-DNA was observed in both
TGGA and AGGC sequence contexts (data not shown).
The 50N7-Pt-50NHx and the 30N7-Pt-30NHx bond angles
also showed a slightly greater range for CP-DNA com-
pared to OX-DNA (Figure 2C–D). However, there was
essentially no diﬀerence between CP- and OX-DNA in the
50N7-Pt-30N7 bond angle, presumably because of the con-
straints imposed by the DNA (Figure 2A). Thus, overall,
CP-DNA was more ﬂexible compared to OX-DNA with
respect to the Pt-amines. The greater ﬂexibility of CP com-
pared to OX (especially with respect to the 50NHx-
Pt-30NHx bond angle) may have resulted in the diﬀerences
in local structure of the adduct, leading to diﬀerences in
formation of hydrogen bonds between the drug and the
adjacent bases.
To further characterize the diﬀerences in the ﬂexibility
of CP- and OX-amines, we examined the conformational
ﬂexibility of the N7-Pt-N-H dihedral angles for CP and
OX on both 50 and 30 side of the adduct. The N7-Pt-N-H
dihedral angle (Figure 3A–C) determines the orientation
of the amine hydrogens, which inﬂuences the ability of
those hydrogens to form hydrogen bonds with the adja-
cent bases. The N7-Pt-N-H dihedral angle for the CP-GG
Figure 2. Geometrical parameters of platinum. The distributions of the four angles around the square-planar platinum atom are plotted from the
CP- and OX-TGGA simulations: 50N7-Pt-30N7 (A), 50NHx-Pt-30NHx (B), 50N7-Pt-50NHx (C), 30N7-Pt-30NHx (D). The Pt-amines at the 50 and 30 side
of the adduct are denoted as 50NHx and 30NHx, respectively. The N7s of G6 and G7 that are involved in covalent bonds with Pt are denoted as 50N7
and 30N7, respectively. The frequency distribution histograms were calculated from the structures obtained at every picosecond over the ﬁnal 6ns of
each equilibrated MD simulation, resulting in a total of 30000 structures each for CP-, OX- and undamaged DNA. The distribution is plotted
against the number of structures in the trajectory. The frequency distributions for CP- and OX-TGGA adducts are shown as a dashed line and solid
line, respectively.
Table 1. Frequency of formation of diﬀerent hydrogen bonds between
Pt-amines and adjacent bases
TGGA
CP OX
a
Hydrogen
bond type
Frequency
(%)
Hydrogen
bond type
Frequency
(%)
G7-O6 32 G7-O6 55
A8-N7 13 T17-O4 15
T5-O30 6
None 54 None 23
AGGC
b
CP OX
c
Hydrogen
bond type
Frequency
(%)
Hydrogen
bond type
Frequency
(%)
G7-O6 13 G7-O6 34
A5-N7 40 A5-N7 14
A5-N7+G7-O6 34 A5-N7+G7-O6 45
None 13 None 8
aOnly the equatorial hydrogen of the OX-amine was involved in hydrogen
bonding on the 30 side of the adduct.
bFrom ref. 26.
cBoth equatorial and axial hydrogens of the OX-amine were involved in hydro-
gen bonds on the 50 side, and only equatorial hydrogen of the OX-amine was
involved in hydrogen bonding on the 30 side of the adduct.
Nucleic Acids Research,2009, Vol.37, No. 8 2439adduct has three broad peaks on both the 30 and 50 side of
the adduct because all the hydrogens are equivalent
and sample three diﬀerent orientations. In contrast, the
N7-Pt-N-H dihedral angle for OX has two relatively
narrow peaks in distribution, with the one between
 1008 and  208 representing the equatorial hydrogen
and the one between 208 and 808 representing the axial
hydrogen in the 50 amine. The peaks are reversed for the 30
amine. In both the AGGC sequence context (Figure 3D)
and the TGGA sequence context (Figure 3E), the 30N7-Pt-
30N-H dihedral angle positions the equatorial hydrogen of
OX for the formation of the G7-O6 hydrogen bond, while
the CP hydrogens are less frequently in the right orienta-
tion (compared to OX) for the formation of the G7-O6
hydrogen bond. Similarly in the TGGA sequence context,
only the CP hydrogens spend a signiﬁcant amount of time
in a conformation favorable for the formation of the
A8-N7 hydrogen bond and only the OX equatorial hydro-
gen spends a signiﬁcant amount of time in a conformation
favorable for the formation of the T17-O4 hydrogen bond
(Figure 3E). Finally, in the AGGC sequence context,
the 50N7-Pt-N-H dihedral angle of CP allows one of the
positions of the ammine hydrogens to be highly favorable
for the formation of the A5-N7 hydrogen bond
(Figure 3F), while the equatorial hydrogen in 50 side of
OX has an orientation that is not as favorable as CP for
the formation of the A5-N7 hydrogen bond. Thus, the
allowable N7-Pt-N-H dihedral angles (in part determined
by the carrier ligand) provides a structural basis for the
type and frequency of hydrogen bond formed in CP- and
OX-DNA adducts in the TGGA and AGGC sequence
contexts.
Figure 3. Dihedral angle involved in hydrogen bond formation. The dihedral angle describing the Pt-amine hydrogen orientation while forming
hydrogen bond with adjacent DNA bases is shown for the G7-O6 hydrogen bond in CP-DNA in the AGGC sequence context (A), the A8-N7
hydrogen bond in CP-DNA in the TGGA sequence context (B) and the A5-N7 hydrogen bond in CP-DNA in the AGGC sequence context (C),
respectively. OX has two hydrogens for each Pt-amine—equatorial (eq) and axial (ax). The distribution of the 30N7-Pt-NHx-H dihedral angle is
shown for the AGGC sequence context (D) and the TGGA sequence context (E). The distribution of the 50N7-Pt-NHx-H dihedral angle is shown for
the AGGC sequence context (F). The distribution of dihedral angles involving all the structures of an adduct are plotted in black, distribution of
dihedral angles for structures with the G7-O6 hydrogen bond are plotted in red and that for structures with the hydrogen bond to adjacent base are
plotted in blue. Similarly, distributions for OX-DNA are plotted as a dashed line while those for CP-DNA are plotted as a solid line. The frequency
distribution histograms for the overall distributions were calculated from the ﬁnal 30000 structures (taken every picosecond) for the TGGA and
60000 structures for the AGGC sequence contexts, for the CP-, OX- and undamaged DNA simulations as described in Figure 2. [Simulations in the
AGGC sequence context were performed from two starting structures each as described in Sharma et al. (26).] The frequency distribution for a
particular hydrogen bonded species was obtained from structures that formed that particular hydrogen bond. However, the normalization was
performed over the full 30000 structures to show the relative abundance of diﬀerent hydrogen bonded species.
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distortionsnearthebasetowhichthehydrogenbondisformed
To examine if hydrogen bond formation correlated
with unique conformations in the central 4bp in the
TGGA sequence context, we calculated the KS ratios
for the helical parameters of the central 4bp associated
with the diﬀerent hydrogen bonded species. For both
CP- and OX-DNA, structures forming G7-O6 hydrogen
bond did not have major diﬀerences when compared to
structures forming no hydrogen bonds to the Pt-amines
(Supplementary Figure S3). However, we did observe sig-
niﬁcant diﬀerences when comparing the helical parameters
of structures with CP-A8-N7 hydrogen bond to structures
with the CP-G7-O6 hydrogen bond and in comparing
structures with OX-T17-O4 hydrogen bond to structures
with OX-G7-O6 hydrogen bond (Figure 4). From the KS
ratio map of comparison of structures with the CP-A8-N7
hydrogen bonds to the structures with the CP-G7-O6
hydrogen bond (Figure 4A), we observed the greatest dif-
ferences in the G7-A8 base pair step, especially in rise, roll,
shift, twist and slide parameters. Signiﬁcant diﬀerences
were also observed for G6-G7 shift and G6-C19 opening.
The parameters with major diﬀerences between structures
with CP-A8-N7 hydrogen bond and all other species in
CP-DNA yielded KS ratios of  8–15 indicating that the
CP-A8-N7 hydrogen bonded species had a unique confor-
mation compared to all other species in CP-DNA.
Similarly, we observed from the KS ratio map of compar-
ison of structures with OX-T17-O4 hydrogen bond to
structures with OX-G7-O6 hydrogen bond (Figure 4A)
that the formation of OX-T17-O4 hydrogen bond resulted
in unique conformations at G7-C18 base pair, G7-A8
base-pair step and A8-T17 base pair, as seen in G7-C18
shear, stagger and stretch; G7-A8 slide and A8-T17 buckle
parameters. A signiﬁcant diﬀerence was also observed for
the G6-G7 twist. The same diﬀerences were also seen when
the helical parameters were compared for structures with
the OX-T17-O4 hydrogen bond to structures with no
hydrogen bonds (data not shown).
The distributions of helical parameters of the hydrogen-
bonded species showing major diﬀerences in CP-DNA
and OX-DNA are plotted in Figure 4B and C, respec-
tively. The G6G7A8 portion of the centroid structures
forming the CP-A8-N7/OX-T17-O4 hydrogen bond is
compared with CP-G7-O6/OX-G7-O6 hydrogen bond in
Figure 4D and E, respectively. In summary, we found that
the formation of the minor hydrogen bonds on the 30
ﬂanking base pair in CP- and OX-DNA was associated
with unique conformations on the 30 side of the adduct.
We do not describe here the helical parameters of struc-
tures with T5-O30 hydrogen bond in OX-DNA since this
hydrogen bond was formed only in 6% of the structures
and because binding of HMGB1a to Pt–DNA is primarily
through interactions on the 30 side of the adduct.
OX T17-O4 and CP A8-N7 areconformationally distinct
withrespect to theminor groove
Formation of unique hydrogen bonds by CP- and
OX-DNA to the drug suggested that these hydrogen-
bonded species could lead to structural diﬀerences
between CP- and OX-DNA. When we compared struc-
tures forming the CP-A8-N7 hydrogen bond to structures
forming the OX-T17-O4 hydrogen bond, we did observe
signiﬁcant diﬀerences. When seen facing the minor
groove, the formation of CP-A8-N7 hydrogen bond
shifted the A8-T17 base pair towards the left, while the
formation of OX-T17-O4 hydrogen bond shifted the
A8-T17 base pair to the right (Figure 5A). Thus, the struc-
tural distortions associated with the formation of these
hydrogen bonds are in opposite directions with reference
to the minor groove. Analyzing these diﬀerences quantita-
tively using helical parameters, we observed that the mean
value of G7-A8 slide was  1A ˚ for the CP-A8-N7 hydro-
gen bond, while it was +1.8A ˚ for the OX-T17-O4 hydro-
gen bond (Figure 5B). Similarly, the shift, twist and roll of
the G7-A8 base-pair step were clearly diﬀerent for struc-
tures with CP-A8-N7 hydrogen bond compared to those
with the OX-T17-O4 hydrogen bond (Figure 5B). As
might be expected, these conformational diﬀerences corre-
lated with the T17-O4 atom being closer to the Pt-amine
hydrogen of OX and the A8-N7 atom being closer to the
Pt-ammine hydrogen of CP. In summary, when compar-
ing CP-DNA to OX-DNA, the minor conformations had
distinct distributions of helical parameters in the vicinity
of hydrogen bond formation that were unique to either
CP- or OX-DNA.
In the crystal structure of the HMGB1a-CP-DNA
complex in the TGGA sequence context, Ser41 of
HMGB1a forms a hydrogen bond with N3 atom of the
adenine 30 to Pt-GG adduct (21) (which would correspond
to A8 in our simulations of free Pt–DNA). Mutagenesis
experiments suggest that this hydrogen bond has a minor
( 4-fold) eﬀect on the aﬃnity of HMGB1a for CP-DNA
(20). The formation of the Ser41-A8N3 hydrogen bond is
observed in our simulations of the HMGB1a complexes
with both CP-DNA and OX-DNA (data not shown). In
the HMGB1a-Pt–DNA complexes, structures containing
the Ser41-A8 hydrogen bond have a G7-A8 slide and twist
that is intermediate between that observed in free CP- and
OX-DNA simulations. However, the HMGB1a-Pt–DNA
conformers containing the Ser41-A8 hydrogen bond
have a G7-A8 roll of 0–7.58 and a G7-A8 shift of  1-
0A ˚ , which is very close to the conformation of the
G7-A8 base-pair step seen in structures with T17-O4
hydrogen bond in free Pt–DNA simulations (Supplemen-
tary Figure S4). Thus, structures with the OX-T17-O4
hydrogen bond in free Pt–DNA would aid the formation
of Ser41 hydrogen bond during complex formation, while
structures with CP-A8-N7 hydrogen bonds have the A8 in
a position unfavorable for hydrogen bonding with Ser41
during binding to HMGB1a.
Hydrogenbond formationto N7 ofan adjacent adenineis
associated withhigher bend angles
HMGB1a, whose diﬀerential binding aﬃnity to CP- and
OX-DNA has been experimentally characterized (11,30),
binds speciﬁcally to bent or distorted DNA and bends it
further (31,32). The formation of the Pt-GG adduct
induces a sharp bend in the DNA towards the major
groove and results in the formation of a wide and shallow
Nucleic Acids Research,2009, Vol.37, No. 8 2441Figure 4. Helical parameters in the TGGA sequence context. The conformational diﬀerences in the central 4bp for diﬀerent hydrogen bonded species
in the TGGA sequence context are represented at three diﬀerent levels. The diﬀerences between two hydrogen bonded species in all the 42 parameters
are shown in a heat map (A). For CP-DNA, we compare structures with G7-O6 hydrogen bond to structures with the A8-N7 hydrogen bond and for
OX-DNA we compare structures with G7-O6 hydrogen bond to structures with the T17-O4 hydrogen bond. We represent the diﬀerences as the KS
ratio, which is color-coded (The KS ratio decreases in the order of Red>Blue>White). Plots of histograms of the four helical parameters showing
signiﬁcant diﬀerences for diﬀerent hydrogen bonded species of CP-DNA adduct (B) and OX-DNA adduct (C), are shown with the frequency
distribution calculated as described before. The distribution for structures with no hydrogen bond is plotted in green, for structures with G7-O6
hydrogen bond in plotted in red and for structures with hydrogen bond to the adjacent base is plotted in blue. Alignment of 50G6G7A8 30 base pairs
of the centroid structures forming the CP-G7-O6 hydrogen bond (red) and the CP-A8-N7 hydrogen bond (blue) (D) are shown. Alignment of
50G6G7A8 30 base pairs of the centroid structures forming the OX-G7-O6 hydrogen bond (red) and the OX-T17-O4 hydrogen bond (blue) (E) are
also shown. The structures are aligned based on Pt-G6G7.
2442 Nucleic Acids Research, 2009, Vol. 37,No. 8minor groove which provides multiple sites for interaction
with HMGB1a (21). The higher bend angle of the
Pt–DNA adduct has been postulated to make the binding
of HMGB1a to Pt–DNA energetically more favorable
compared to undamaged DNA (31), and hence the distri-
bution of the bend angles could inﬂuence the preferential
binding of HMG-domain proteins to Pt–DNA. We calcu-
lated the overall bend angle of the central 10bp of the
diﬀerent hydrogen-bonded conformations using the pro-
gram MADBEND (29).
The overall distribution of bend angles indicated that
the platinated DNA is more bent than undamaged DNA
as expected (Figure 6). When we compared CP- and
OX-GG adducts in the TGGA sequence context, we
observed a higher population of structures in CP-GG
adduct compared to OX-GG adduct having bend angles
close to 58.98, which is the bend angle of CP-DNA bound
to HMGB1a found in its crystal structure (21) (repre-
sented as a dashed vertical line in Figure 6). When we
computed the percentage of species having bend angles
 108 of the bend angle of CP-DNA bound to
HMGB1a, we found that CP-GG had 10.25% of the pop-
ulation in this region, while OX-GG adduct had only
5.86% of its population in this region. The situation was
reversed in the AGGC sequence context, where OX
had 22.15% of the population within  108 of the bend
angle of CP-DNA bound to HMGB1a [in its crystal
structure (21)], while CP-GG adduct had only 15.24% of
the population in the higher bend angle region of the
distribution.
Upon clustering the distribution of bend angles based
on hydrogen bond formation, we observed signiﬁcant cor-
relation between hydrogen bond pattern and bend angle
(Supplementary Figure S5, Table 2). In the TGGA
sequence context, the A8-N7 hydrogen bond formed by
the CP-GG adduct was associated with higher bend angles
(mean bend angle of 44.38) compared to species with no
hydrogen bonds (29.88) and with the G7-O6 hydrogen
bond (29.98). For the OX-GG adduct, no single species
stood out with higher mean bend angle. In the AGGC
sequence context, the formation of A5-N7 hydrogen
Figure 5. Diﬀerences in DNA conformation and helical parameters
of A8-N7 and T17-O4 hydrogen bonded species in CP- and OX-
DNA, respectively. (A) Alignment of the 50G6G7A8 30 base pairs of
the centroid structures forming A8-N7 hydrogen bond in CP-DNA
adduct and the T17-O4 hydrogen bond in the OX-DNA adduct is
shown. The structures are aligned based on Pt-G6G7. (B) Plots of
histograms of the four helical parameters showing greatest diﬀerences
between the A8-N7 hydrogen bonded species in CP-DNA and T17-O4
hydrogen bonded species in OX-DNA are shown. The distributions
of twist, slide, roll and shift parameters of the G7-A8 base-pair step
are plotted because the greatest diﬀerences are in this base-pair
step (data not shown). The solid line represents distribution of struc-
tures with CP-A8-N7 hydrogen bond while the dashed line
represents distribution of structures with OX-T17-O4 hydrogen bond.
The frequency distributions are calculated and normalized as described
earlier.
Figure 6. Bend angle distributions of hydrogen-bonded species. The
bend angle distributions of CP-, OX-GG adducts and undamaged
DNA in the TGGA and the AGGC sequence context are plotted.
The distribution for undamaged DNA is plotted as a solid line, the
distribution for CP-DNA is plotted as a dotted line and that for OX-
DNA is plotted as a dashed line. The bend angle of DNA in the crystal
structure of CP-DNA bound to HMGB1a (21) is plotted as a vertical
dashed line. The region of bend angle  108 of the bend angle in the
crystal structure of CP-DNA bound to HMGB1a is plotted alongside
to highlight diﬀerences between CP- and OX-GG adducts.
Nucleic Acids Research,2009, Vol.37, No. 8 2443bond was associated with a higher bend angle compared
to the structures with the G7-O6 hydrogen bond or no
hydrogen bonds with the drug for both CP- and OX-
GG adducts. In summary, higher bend angles were asso-
ciated with hydrogen bond formation to adjacent adenines
in both TGGA and AGGC sequence contexts, which gave
a signiﬁcant advantage to the CP-GG adduct in the
TGGA sequence context and a slight advantage to the
OX-GG adduct in the AGGC sequence context in terms
of interaction with HMGB1a.
Hydrogenbond formationto N7 ofan adjacentadenine is
associated withhigher roll inthe platinated base-pair step
Binding of HMB1a to Pt–DNA involves the intercalation
of Phe37 in the platinated base-pair step, resulting in the
roll of this base-pair step being 56.78 (21). Thus, ability to
sample higher roll could result in better binding aﬃnity for
Pt–DNA. The G6-G7 base-pair step has a mean roll of
3.38 and 5.38 in undamaged DNA in the TGGA and
AGGC sequence contexts, respectively. The formation of
either CP- or OX-G6G7 adducts shifted the G6-G7 roll to
signiﬁcantly higher values compared to undamaged DNA
(Figure 7). There was also a pronounced shoulder in the
distributions of G6G7 roll parameters in Pt–DNA adducts
in both TGGA and AGGC sequence contexts (Figure 7).
This shoulder lies in the region that is favorable for bind-
ing of HMGB1a, and diﬀers between CP- and OX-GG
adducts to diﬀerent extents in diﬀerent sequence contexts.
In the TGGA sequence context, the CP-GG adduct
explored conformations with G6G7 roll  108 of the roll
of CP-DNA bound to HMGB1a 3.2 times more fre-
quently than OX-GG adducts, while in the AGGC
sequence context, CP- and OX-GG adducts explored
rolls within  108 of the roll of CP-DNA bound to
HMGB1a to about the same extent.
The distributions with higher roll were mainly com-
prised of structures forming the CP-A8-N7 hydrogen
bond in the TGGA sequence context (Supplementary
Figure S6), while in the AGGC sequence context, the
regions of high roll were associated mainly with the for-
mation of both CP- and OX-A5-N7 hydrogen bond
(Supplementary Figure S6). Thus, hydrogen bonding to
adjacent adenine in both sequence contexts was associated
with higher roll in the G6G7 base-pair step.
The diﬀerence between CP- and OX-DNA in the roll of
the G6-G7 base-pair step may be signiﬁcant for HMGB1a
binding to Pt–DNA adducts. Ohndorf et al. (21) have
shown that the crystal structure of the HMGB1a-CP-
DNA complex has signiﬁcantly greater roll (56.78) at the
platinated GG base-pair step than free CP-DNA and have
postulated that the greater roll enables ideal geometry for
p–p stacking of Phe37 of HMGB1a with the 30 guanine of
the platinated base-pair step. This interaction appears to
be particularly important for the stability of the
HMGB1a-Pt–DNA complex, since the Phe37Ala muta-
tion reduces binding aﬃnity >667-fold. The ability of
free CP-DNA in the TGGA sequence context and both
free CP- and OX-DNA in the AGGC sequence context
(but not free OX-DNA in the TGGA sequence context) to
sample roll at values seen in the crystal structure of
the HMGB1a-CP-DNA complex would suggest that
these Pt–DNA adducts have the conformational ﬂexibility
to readily form the HMGB1a-Pt–DNA complex. In con-
trast, OX-TGGA alone samples lower roll angles at the
platinated base-pair step, suggesting that it would have
more diﬃculty forming a complex that has optimal stack-
ing of Phe37 to the 30G. As might be expected, our simu-
lations of the HMGB1a complexes with Pt–DNA show
that indeed the mean platinated base-pair roll of
OX-TGGA is downshifted by  3.28 compared to the
roll seen in CP- and OX-AGGC and CP-TGGA and
Figure 7. Distribution of the G6-G7 roll. The distribution of G6-G7
roll, which is important for intercalation of Phe37 of HMGB1a
between the G6-G7 base-pair step is plotted for the AGGC and the
TGGA sequence contexts. The distributions of CP-, OX- and unda-
maged DNA are plotted in each sequence context. The distribution for
undamaged DNA is plotted as a solid line, the distribution for
CP-DNA is plotted as a dashed line and that for OX-DNA is plotted
as a dotted line. The bend angle of DNA in the crystal structure of
CP-DNA bound to HMGB1a (21) is plotted as a vertical dashed line.
The region of roll  108 of the roll in the crystal structure of CP-DNA
bound to HMGB1a is plotted alongside to highlight diﬀerences
between CP- and OX-DNA in the TGGA sequence context.
Table 2. Bend angle distributions
CP OX
Hydrogen
bond type
Frequency
(%)
Mean
bend
angle
(8)
Hydrogen
bond
type
Frequency
(%)
Mean
bend
angle
(8)
TGGA
A8-N7 13 44.3 T17-O4 15 35.3
G7-O6 32 29.9 G7-O6 55 28.5
None 54 29.9 None 23 29.9
AGGC
A5-N7 40 36.3 A5-N7 14 40.2
A5-N7+
G7 O6
34 36.0 A5-N7+
G7 O6
45 39.7
G7-O6 13 28.3 G7-O6 34 31.2
None 13 28.8 None 8 33.0
2444 Nucleic Acids Research, 2009, Vol. 37,No. 8in the crystal structure of the HMGB1a-CP-DNA com-
plex (Figure 8).
In summary, CP-DNA in the TGGA sequence context
was able to sample conformations that resulted in a high
roll in the G6G7 base-pair step, which has been suggested
to favor binding to HMGB1a (21), while OX-DNA in the
same sequence context was unable to sample these con-
formations. Contrastingly, both CP- and OX-DNA
sampled conformations with a high roll in the G6G7
base-pair step to the same extent in the AGGC sequence
context. Furthermore, these diﬀerences in roll between
CP- and OX-DNA adducts in the TGGA sequence con-
text appear to be preserved in the complexes with
HMGB1a.
DISCUSSION
The goal of this study was to uncover the conformational
diﬀerences between CP- and OX-GG adducts which could
explain the diﬀerential binding aﬃnities of cellular pro-
teins to these adducts. The molecular basis of these diﬀer-
ential binding aﬃnities is not clear and understanding the
underlying mechanism may throw light on the contrasting
downstream eﬀects of CP- and OX-GG adducts at the
cellular level. It has been hypothesized that the diﬀerent
downstream eﬀects of CP- and OX-GG adducts are
caused in part by the diﬀerential binding aﬃnities of cel-
lular damage-recognition proteins to CP- and OX-GG
adducts (8,16,18,33–35). Further, it has been shown
that HMGB1a binds to CP-GG adducts with approxi-
mately the same aﬃnity in both the TGGA and AGGC
sequence contexts, while it binds to OX-GG adducts
with  3-fold lower aﬃnity in the AGGC sequence con-
text and 53-fold lower aﬃnity in the TGGA sequence
context (18). Thus, the binding aﬃnity of HMGB1a to
Pt-GG adducts is dependent both on the carrier ligand
and the sequence context. We have postulated that the
diﬀerences in binding aﬃnity to CP- and OX-DNA by
Pt–DNA binding proteins is due to the diﬀerences in
their conformational dynamics, i.e. the time spent by
CP- and OX-DNA adducts in various conformations
favorable for binding (26).
From our simulations of free Pt–DNA in the TGGA
sequence context, we were able to identify various confor-
mations on the basis of the pattern of hydrogen bonds
between Pt-amines and the DNA. The major conforma-
tions, which are characterized by either no hydrogen
bonds being formed or hydrogen bond formed with
G7-O6, have similar structural parameters, which explains
the lack of diﬀerences in the overall centroid structures in
these simulations and the lack of major conformational
diﬀerences between CP- and OX-GG adducts in previous
NMR and crystal structures. However, the minor confor-
mations, which are accompanied by hydrogen bonds to
bases adjacent to the Pt-GG, feature signiﬁcantly diﬀerent
structural parameters that are unique to both CP- and
OX-GG adducts. The diﬀerences in hydrogen bond pat-
terns between CP- and OX-GG adducts appear to be due
to constraints imposed by the cyclohexane ring on the
amine-Pt-amine bond angle and the N7-Pt-N-H dihedral
angle. If conformational dynamics inﬂuence the diﬀer-
ences in the binding aﬃnity of HMGB1a to CP- and
OX-DNA, then we would expect these minor conforma-
tions to have distinct aspects of structural parameters that
favor binding by HMGB1a.
The crystal structure of HMGB1a-Pt–DNA complex
reveals a number of hydrophobic contacts and hydrogen
bonds between HMGB1a and the DNA minor groove.
Given that HMGB1a has been shown not to make any
sequence-speciﬁc contacts with its target DNA (21), the
ﬂexibility and bending ability of free Pt–DNA could
have a major inﬂuence on the binding aﬃnity. The aﬃnity
of HMGB1a for Pt–DNA adducts appears to be strongly
inﬂuenced by three conformational features of DNA con-
taining Pt-GG adducts: overall bend angle, Phe37 stacking
with the 30G of the Pt-GG adduct and, in the TGGA
sequence context, hydrogen bond formation between
Ser41 and the 30A. The overall bend angle is important
because bending of the DNA towards the major groove
favors formation of a widened minor groove opposite the
Pt-GG adduct which serves as the binding site for
HMGB1a (31). However, based on both the crystal struc-
ture and mutagenesis studies, the p–p stacking of Phe37
with the 30G appears to be of primary importance, with
the Ser41 hydrogen bond with the 30AN3 in the TGGA
sequence context being of secondary importance (20,21).
The eﬀects of the other interactions of HMGB1a with the
Figure 8. Distributions of the Pt-GG roll in the HMGB1a-Pt–DNA
simulations. The distribution of the roll of the Pt-GG base-pair step,
which is important for stacking of Phe37 of HMGB1a to the 30Gi s
plotted for the HMGB1a-Pt–DNA complexes in the AGGC and the
TGGA sequence contexts. The distributions of the roll of CP- and OX-
DNA are plotted for each sequence context. Distributions of adducts in
the TGGA sequence context are plotted as solid lines, while the dis-
tributions of adducts in the AGGC sequence context are plotted as
dashed lines. CP-DNA is plotted in black, while OX-DNA is plotted
in red. The dashed vertical line represents the roll of the G6-G7 base-
pair step from the HMGB1a-CP-DNA crystal structure. The frequency
distribution histograms were calculated from the structures obtained at
every picosecond over the ﬁnal 45ns of each equilibrated MD simula-
tion, resulting in a total of 45000 structures each for CP- and
OX-DNA in the TGGA and AGGC sequence contexts. The distribu-
tion is plotted against the number of structures in the trajectory.
Nucleic Acids Research,2009, Vol.37, No. 8 2445widened minor groove Pt–DNA adducts have not been
characterized, but are likely to be of less or equal signiﬁ-
cance than the Ser41 hydrogen bond.
Pt–DNA adducts that can sample higher bend angles
would be expected to be bound by HMGB1a with greater
aﬃnity (36). We observed that higher bend angle was asso-
ciated with hydrogen bonding to adjacent adenine for
both CP- and OX-GG adducts. In the TGGA sequence
context, CP-GG adduct can form A8-N7 hydrogen bond
and can also sample higher bend angles more frequently,
while OX-GG adduct does not form the A8-N7 hydrogen
bond and samples higher bend angles less frequently com-
pared to CP-GG adducts. In the AGGC sequence context,
both CP- and OX-GG adducts form the A5-N7 hydrogen
bond and sample high bend angles, with OX-DNA
adducts sampling at high bend angles at a slightly higher
frequency than CP-DNA adducts. Thus, CP- and OX-
DNA in AGGC sequence context and CP-DNA in
TGGA sequence context but not OX-DNA in TGGA
sequence context sample bend angles that would favor
binding to HMGB1a.
In addition, the binding of HMGB1a to Pt–DNA
adducts involves intercalation of Phe37 into the Pt-GG
base-pair step, which is associated with an unusually
large roll and dihedral angle at that base-pair step.
Thus, HMGB1a would likely have a higher aﬃnity for
DNA structures that favor high roll in the G6G7 base-
pair step. In our simulations, we observed that CP-DNA is
able to sample structures with roll  108 of the roll of
CP-DNA bound to HMGB1a signiﬁcantly more than
OX-DNA in the TGGA sequence context, while in the
AGGC sequence context, the populations of CP- and
OX-DNA in this region were essentially the same. The
diﬀerences seen in free Pt–DNA simulations are reﬂected
in the simulations of HMGB1a-Pt–DNA simulations,
where OX-DNA in the TGGA sequence context has a
mean roll that is less than that of CP-DNA. The geometry
of the Pt-GG base-pair step in the HMGB1a-Pt–DNA
crystal structure is ideal for p–p stacking of Phe37 of
HMGB1a with the 30G, and deviations from this geometry
are expected to decrease binding aﬃnity. Decrease in the
roll of Pt-GG implies decreased surface area of 30G that is
exposed for the stacking interaction. This agrees well with
gel shift data, which shows appreciable binding of
HMGB1a to CP- and OX-DNA in the AGGC sequence
context, and to CP-DNA in the TGGA sequence context,
but not to OX-DNA in the TGGA sequence context (18).
Finally, DNA helical parameters at the G7N8 base-pair
step also appear to inﬂuence the aﬃnity of HMGB1a
for Pt–DNA adducts. In the TGGA sequence context,
the formation of a hydrogen bond between Ser41 and
the 30A contributes to the stability of the HMGB1a-
Pt–DNA complex (20), and the roll and shift of G7-A8
base-pair step appear to favor formation of this hydrogen
bond between HMGB1a and OX-DNA during complex
formation. In a previous comparison of the conforma-
tional dynamics of CP- and OX-GG DNA adducts in
the AGGC sequence context (26), we found that the
shift and slide of the G7-C8 base-pair step of CP-GG
adduct favored binding of HMGB1a to the CP-GG
adducts.
In summary, the speciﬁcity of binding of HMGB1a to
Pt–DNA adducts is inﬂuenced by a number of complex
structural features. In the case of CP- and OX-GG DNA
adducts in the TGGA sequence context, the ability of
CP-GG adducts to explore greater bend angles and
greater roll at the G6G7 base-pair step favors Phe37 p–p
stacking with G7. Both of these conformational features
favor binding of HMGB1a to CP-GG adducts. In con-
trast, the conformations explored by the DNA at the
G7A8 base-pair step favor formation of the Ser41-A8
hydrogen bond, which in turn favors binding of
HMGB1a to the OX-GG adduct. The quantitative eﬀect
of DNA bending on the aﬃnity of HMGB1a for Pt–DNA
adducts has not been established, but the eﬀect of Phe37
stacking with the 30G is much greater than formation
of the Ser41-A8N3 hydrogen bond (20), which might
explain the observed 53 times higher binding aﬃnity
of HMGB1a towards CP-GG adducts compared to
OX-GG adducts in the TGGA sequence context (18).
For the AGGC sequence context, diﬀerences in several
helical parameters at the G7A8 base-pair step favor bind-
ing of CP-GG adduct to HMGB1a, while roll at the G6G7
base-pair step does not appear to oﬀer a signiﬁcant
advantage to either CP- or OX-GG adducts and the over-
all bend angle favors OX-GG adduct slightly, per-
haps explaining the just three times higher aﬃnity of
HMGB1a towards CP-GG adduct compared to OX-GG
adduct in that sequence context (11,18).
We have demonstrated here that the sequence depen-
dent diﬀerences in conformational dynamics of CP- and
OX-DNA correlate with hydrogen bond formation
between the Pt-amines and adjacent bases. However, the
formation of hydrogen bonds poses an interesting ques-
tion in terms of cause-eﬀect: is it the hydrogen bonds that
drive these unique conformations, or is it the sequence
dependent conformations that allow the formation of
hydrogen bonds? Since previous binding studies with
DNA which had 7-deazapurines ﬂanking Pt-GG revealed
no changes in binding aﬃnities of HMGB1a toward
CP-DNA (37) and the roll at the G6G7 base-pair step is
more constrained for OX-DNA in the HMGB1a-OX-
DNA complex even though hydrogen bond formation
between Pt-amines and adjacent bases is minimal, we con-
sider it likely that the hydrogen bonds do not drive these
conformations. However, the association of hydrogen
bond formation with conformations that are unique to
CP- and OX-DNA have provided us an avenue to char-
acterize the conformational dynamics of Pt-GG adducts.
Apart from HMG-domain proteins, other cellular pro-
teins have also been observed to show diﬀerential binding
aﬃnity to CP- and OX-DNA adducts, which may have
possible functional signiﬁcance. The mismatch repair pro-
teins, MutS and hMSH2 have been observed to bind with
higher aﬃnity to CP-DNA compared to OX-DNA and it
has been shown that mismatch repair deﬁcient cells were
resistant to CP- but not to OX. Thus, mismatch repair
proteins have an important role in CP toxicity but not
OX toxicity. The diﬀerences in conformational dynamics
could certainly contribute to the diﬀerential aﬃnities in
mismatch repair proteins, but structural information and
mutational studies on hMSH2 and MutS are limited and
2446 Nucleic Acids Research, 2009, Vol. 37,No. 8out of the scope of this article. Similarly, error-prone poly-
merases are another group of proteins that have been
shown to functionally discriminate CP- and OX-DNA
adducts, and the conformational diﬀerences observed
here might have an important role in the interactions of
Pt–DNA with the error-prone polymerases as well.
To summarize, we showed that the conformational
dynamics of CP- and OX-DNA are diﬀerent. The diﬀer-
ences in conformational dynamics between CP- and
OX-DNA are likely determined by the constraints on
the NHx-Pt-NHx bond angles and the N7-Pt-N-H dihe-
dral angles, which in turn depended on both the sequence
context and carrier ligand of the Pt-GG adduct. These
diﬀerences may explain the dependence of sequence con-
text on the extent of diﬀerential binding of HMGB1a to
CP- and OX-DNA adducts. These diﬀerences in confor-
mational dynamics may also contribute to the diﬀerential
binding of mismatch repair proteins to CP- and OX-DNA
adducts and also the diﬀerential translesion replication of
these adducts by error-prone polymerases. Thus, the dif-
ferential conformational dynamics of CP- and OX-DNA
could contribute to the diﬀerences in eﬃcacy and toxicity
of these drugs.
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